Elekta AB (publ) (EKTAY)
USD 4.93
(1.75%)
USD 4.93
(1.75%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 4.46 Billion SEK | 31.75% |
| 2023 | 3.39 Billion SEK | 29.4% |
| 2022 | 2.62 Billion SEK | 43.03% |
| 2021 | 1.83 Billion SEK | -37.95% |
| 2020 | 2.95 Billion SEK | 500.2% |
| 2019 | 493 Million SEK | -44.36% |
| 2018 | 886 Million SEK | -53.1% |
| 2017 | 1.88 Billion SEK | -29.44% |
| 2016 | 2.67 Billion SEK | -3.29% |
| 2015 | 2.76 Billion SEK | 23.63% |
| 2014 | 2.23 Billion SEK | 12.8% |
| 2013 | 1.98 Billion SEK | -24.67% |
| 2012 | 2.63 Billion SEK | 646.68% |
| 2011 | -482 Million SEK | -147.35% |
| 2010 | 1.01 Billion SEK | 27.41% |
| 2009 | 799 Million SEK | -23.69% |
| 2008 | 1.04 Billion SEK | 108.15% |
| 2007 | 503 Million SEK | 357.27% |
| 2006 | 110 Million SEK | 23.6% |
| 2005 | 89 Million SEK | 111.63% |
| 2004 | -765 Million SEK | -25.2% |
| 2003 | -611 Million SEK | -21.96% |
| 2002 | -501 Million SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 4.97 Billion SEK | 13.68% |
| 2024 Q3 | 4.79 Billion SEK | -3.78% |
| 2024 Q4 | 4.46 Billion SEK | -6.7% |
| 2024 FY | 4.46 Billion SEK | 31.52% |
| 2024 Q1 | 4.37 Billion SEK | 28.87% |
| 2023 Q3 | 4.42 Billion SEK | 5.92% |
| 2023 Q1 | 3.27 Billion SEK | 24.75% |
| 2023 Q4 | 3.39 Billion SEK | -23.14% |
| 2023 FY | 3.39 Billion SEK | 29.4% |
| 2023 Q2 | 4.17 Billion SEK | 27.41% |
| 2022 Q3 | 2.81 Billion SEK | -0.81% |
| 2022 Q1 | 2.21 Billion SEK | 20.59% |
| 2022 Q2 | 2.84 Billion SEK | 28.27% |
| 2022 FY | 2.62 Billion SEK | 43.03% |
| 2022 Q4 | 2.62 Billion SEK | -6.78% |
| 2021 FY | 1.83 Billion SEK | -37.95% |
| 2021 Q4 | 1.83 Billion SEK | -15.7% |
| 2021 Q3 | 2.17 Billion SEK | -28.71% |
| 2021 Q1 | 3.09 Billion SEK | 4.6% |
| 2021 Q2 | 3.05 Billion SEK | -1.29% |
| 2020 FY | 2.95 Billion SEK | 500.2% |
| 2020 Q3 | 3.44 Billion SEK | 22.74% |
| 2020 Q4 | 2.95 Billion SEK | -14.21% |
| 2020 Q2 | 2.81 Billion SEK | 13.4% |
| 2020 Q1 | 2.47 Billion SEK | 402.64% |
| 2019 Q1 | 1.39 Billion SEK | 57.0% |
| 2019 FY | 493 Million SEK | -44.36% |
| 2019 Q4 | 493 Million SEK | -68.5% |
| 2019 Q2 | 1.33 Billion SEK | -3.95% |
| 2019 Q3 | 1.56 Billion SEK | 17.14% |
| 2018 Q1 | 1.91 Billion SEK | 1.27% |
| 2018 Q2 | 2.02 Billion SEK | 5.85% |
| 2018 Q3 | 1.54 Billion SEK | -23.95% |
| 2018 FY | 886 Million SEK | -53.1% |
| 2018 Q4 | 886 Million SEK | -42.47% |
| 2017 Q1 | 3.03 Billion SEK | 13.26% |
| 2017 Q4 | 1.88 Billion SEK | -33.63% |
| 2017 Q3 | 2.84 Billion SEK | -6.96% |
| 2017 Q2 | 3.05 Billion SEK | 0.89% |
| 2017 FY | 1.88 Billion SEK | -29.44% |
| 2016 Q4 | 2.67 Billion SEK | -20.42% |
| 2016 Q1 | 3.4 Billion SEK | 22.94% |
| 2016 FY | 2.67 Billion SEK | -3.29% |
| 2016 Q2 | 3.45 Billion SEK | 1.53% |
| 2016 Q3 | 3.36 Billion SEK | -2.63% |
| 2015 Q3 | 4.02 Billion SEK | 8.11% |
| 2015 Q4 | 2.76 Billion SEK | -31.23% |
| 2015 Q2 | 3.72 Billion SEK | 23.89% |
| 2015 Q1 | 3 Billion SEK | 34.21% |
| 2015 FY | 2.76 Billion SEK | 23.63% |
| 2014 Q3 | 3.3 Billion SEK | 1.66% |
| 2014 Q4 | 2.23 Billion SEK | -32.15% |
| 2014 Q2 | 3.24 Billion SEK | 23.28% |
| 2014 Q1 | 2.63 Billion SEK | 32.64% |
| 2014 FY | 2.23 Billion SEK | 12.8% |
| 2013 Q4 | 1.98 Billion SEK | -29.66% |
| 2013 FY | 1.98 Billion SEK | -24.67% |
| 2013 Q3 | 2.82 Billion SEK | -2.56% |
| 2013 Q2 | 2.89 Billion SEK | -30.63% |
| 2013 Q1 | 4.17 Billion SEK | 58.44% |
| 2012 Q4 | 2.63 Billion SEK | -8.38% |
| 2012 FY | 2.63 Billion SEK | 646.68% |
| 2012 Q1 | -600 Million SEK | -24.48% |
| 2012 Q2 | 2.96 Billion SEK | 594.67% |
| 2012 Q3 | 2.87 Billion SEK | -3.1% |
| 2011 Q4 | -482 Million SEK | -342.2% |
| 2011 Q1 | 173 Million SEK | -83.01% |
| 2011 Q2 | 1.39 Billion SEK | 706.36% |
| 2011 Q3 | -109 Million SEK | -107.81% |
| 2011 FY | -482 Million SEK | -147.35% |
| 2010 FY | 1.01 Billion SEK | 27.41% |
| 2010 Q4 | 1.01 Billion SEK | 0.0% |
| 2009 FY | 799 Million SEK | -23.69% |
| 2008 FY | 1.04 Billion SEK | 108.15% |
| 2007 FY | 503 Million SEK | 357.27% |
| 2006 FY | 110 Million SEK | 23.6% |
| 2005 FY | 89 Million SEK | 111.63% |
| 2004 FY | -765 Million SEK | -25.2% |
| 2003 FY | -611 Million SEK | -21.96% |
| 2002 FY | -501 Million SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | -931657.956% |
| Ansell Limited | -54.99 Million USD | 8225.917% |
| Ansell Limited | -55.1 Million USD | 8210.708% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 12346.128% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 4252159.904% |
| Psykey, Inc. | 634.59 Thousand USD | -704130.901% |
| ConvaTec Group Plc | 1.2 Billion USD | -272.23% |
| ConvaTec Group Plc | 1.2 Billion USD | -271.704% |
| Encision Inc. | 1.29 Million USD | -346148.101% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -193470.715% |
| Innovative MedTech Inc. | 1.76 Million USD | -253139.011% |
| LifePoint, Inc. | -3.26 Million USD | 137017.011% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | -91026.308% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | -206606.753% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 10320162.812% |
| Reflect Scientific, Inc. | -1.03 Million USD | 431759.402% |
| SmileDirectClub, Inc. | 778.67 Million USD | -473.922% |
| Sector 10, Inc. | 163 Thousand USD | -2741617.791% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 1170.28% |
| SheerVision, Inc. | 57.34 Thousand USD | -7792538.058% |
| United Health Products, Inc. | 660.56 Thousand USD | -676437.954% |
| Vasamed, Inc. | 22.12 Thousand USD | -20201509.258% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | -169745.231% |
| Yubo International Biotech Limited | 772.27 Thousand USD | -578576.877% |